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Based on the diverse biological properties of curcumin, we synthesized and tested curcumin mimics libraries by using several screening systems to identify more enhanced effects and undiscovered activities. For example, amide linked curcumin mimics (2) showed an angiogenesis inhibition effect 7 and sulfonyl amide-linked curcumin derivatives (3) exhibit a vasodilatation effect on the basilar artery of white rabbit induced by high K + ion. 8 In addition, we found that substituted triazolyl curcumin derivatives (4) exhibited moderate to strong inhibitory activity against osteoclastogenesis induced by the receptor activator of nuclear factor (NF)-κB ligand (RANKL). 9 Curcumin derivatives (5) with benzimidazole groups exhibited cytotoxicity against various cancer cells 10 and, particularly, strongly inhibited multi-drug resistant cancer cells.
11 Our results and those of previous studies show that the relationship between structural modification and biological properties, strongly depends on the identity of the functional groups attached to the feruloyl structure.
Among the useful biological properties of curcumin, the inhibitory property against adipocyte proliferation and differentiation has received significant attention because these processes are critical in the development of obesity, which is a main cause of chronic diseases such as type II diabetes and cardiovascular disease.
12 Ha et al. suggested that curcumin suppresses adipogenesis of 3T3-L1 cells through the Wnt signaling pathway. 13 Park et al. also reported that curcumin regulates several targets such as peroxisome proliferatoractivated receptor (PPAR)-γ, Map kinases, and cyclooxygenase (COX)-2 by stimulating AMP-activated protein kinase (AMPK).
14 Although the usefulness and mechanistic pathway of curcumin for inhibiting the differentiation of adipocytes has been determined in several studies, 12-14 potential drug candidates for controlling obesity and its associated chronic diseases remain unknown. Here, we describe the design and synthesis of a novel curcumin mimics library and their anti-differentiation properties toward adipocyte.
To accurately determine the structure of curcumin mimics and obtain their structure-activity relationships, we selected 4 types of benzaldehyde (6a-6d) and 2 aminoacetophenones (7 and 8) as shown in Scheme 1. Two groups of important Scheme 1. Synthesis of 3'-aminochalcone (9a-9d) and 4'-aminochalcone (10a-10d) intermediates. The yields for each intermediates: 9a (35%); 9b (32%); 9c (35%); 9d (36%); 10a (34%); 10b (32%); 10c (31%); 10d (29%). Notes synthetic intermediate (9a-9d and 10a-10d) were obtained from the aldol reaction of various benzaldehydes (6a-6d) with 2 aminoacetophenones (7 and 8) in the presence of a basic catalyst (40% KOH) in ethanol at room temperature for 10 h. 15 These intermediates were used to synthesize curcumin mimics such as 2, shown in Figure 1 , which is classified as an asymmetric curcumin mimic with additional binding groups different from those of curcumin (1) . Particularly, we obtained the mimics from these intermediates (9a-9d and 10a-10d) with variability at the left benzene ring and the meta-and para-position of additional amide linkages.
In order to add a diverse functional group to 3'-aminochalcone (9a-9d) and 4'-aminochalcone (10a-10d) to synthesize the amide-linked curcumin mimics library, 3 types of acryloyl chloride with a 3,4-substituted phenyl group (12a-12c) were synthesized via acetylation with acetic anhydride in pyridine, 16 which is needed to avoid self-condensation between the phenol group and acyl chloride of 12a-12c.
17
Chlorination with thionyl chloride to carboxylic acid groups in benzene was successively conducted from each starting material, ferulic acid (11a), isoferulic acid (11b), and pcoumaric acid (11c). The substitution reaction of acyl chloride compounds, 12a-12c, with 2 aminochalcones, 9a-9d and 10a-10d, in pyridine and tetrahydrohuran (THF) gives structurally diversified asymmetric amide-linked curcumin mimics (13a-13l and 14a-14l), which were converted into 15a-15l and 16a-16l by deprotection of the acetyl group using K 2 CO 3 in dichloromethane/ethanol (1:1). 16 ExperiScheme 2. Synthesis of asymmetric curcumin mimics library, 13a-13l and 15a-15l, from 3'-aminochalcone (9a-9d) and, 14a-14l and 16a-16l, from 4'-aminochalcone (10a-10d) intermediates. mental detail for synthesizing the curcumin mimics library shown in Scheme 2 is included in the supporting information.
Based on previous reports [12] [13] [14] stating that curcumin inhibits the proliferation and differentiation of 3T3-L1 preadipocytes, we tested the effect of our in-house curcumin mimics library on adipocyte differentiation. 18 After evaluation of cell viability using the MTT assay of the asymmetrical curcumin mimic library against 3T3-L1 at a single concentration of 10 μM, 16 compounds showing less than 70% cell viability were ruled out (data for cytotoxicity not shown). The tested compounds generally showed stronger inhibitory concentration or somewhat weak activity compared to the lead compound, curcumin (1) .
However, the most of the components in the tested library exhibited stronger activity than other positive control, resveratrol (Res.), as shown in Table 1 . When considering the strength of inhibition against the proliferation and differentiation of 3T3-L1 adipocyte, some differences were observed that depend on their structure. For example, deacetylated curcumin mimics (15a-15l and 16a-16l) showed weaker inhibitory activity than the acetylated curcumin mimics (13a-13l and 14a-14l), indicating that the hydrogen bond donor of the free phenol group in 15a-15l and 16a-16l may give a negative effect to improve an inhibition against adipocyte differentiation. Interestingly, compounds c, e, and g of 13-16 compounds showed strong cell cytotoxicity and was excluded from the test. Additionally, the meta-or paraposition of the amide group did not correlate with the potency of inhibition. Results of microscopy studies of Oil red O stainied curcumin (1) and 14k, the most potent inhibitor among in the library, are shown in Figure 2 . Curcumin (1) effectively inhibited differentiation of 3T3-L1 cells at the concentration of 20 μM, but showed minimal inhibition at 10 and 5 μM. However, 14k strongly inhibited adipocyte differentiation at 10 and 5 μM without cell cytotoxicity, indicating 14k showed inhibitory activity against the differentiation of 3T3-L1 adipocyte in a dose-dependent manner. The other active compounds also exhibited a similar tendency for inhibition.
In conclusion, a curcumin mimics library (13a-13l, 14a-14l) created through the substitution reaction of α,β-unsaturated carbonyl chlorides (12a-12c) with 3'-aminochalcone (9a-9d) and 4'-aminochalcone (10a-10d) and their deacetylated library (15a-15l, and 16a-16l) were synthesized to identify novel anti-obesity drug candidates that inhibit the proliferation and differentiation of 3T3-L1 adipocyte. Based on adipogenesis tests using Oil Red O staining, we confirmed that our curcumin mimics library contains stronger inhibitors than 2 natural products, curcumin and resveratrol although several compounds showed cell cytotoxicity. In the tested library, 8 compounds (13a, 13b, 13i, 13l, 14d, 14f, 14i, and 14k) were found to be strong candidates for inhibiting preadipocyte differentiation, which will be examined in mechanistic studies.
